Deals and cases

Deals and cases

Browse our deals and cases

Filter information in our deals and cases database

  • 22.09.2022

    TGS Baltic represented InMedica in the acquisition of Vilnius Implantology Center Clinic 

    Our client InMedica has signed the deal for acquisition of 100% of Vilnius Implantology Center Clinic from OP Group, whose co-owner is DMSc Algirdas Puišys, the founder of the clinic.

  • 09.08.2022

    TGS Baltic advised the shareholders of Kilo Health in the sale of minor part of company shares to Scandinavian and Estonian funds

    TGS Baltic M&A team consisting of Marius Matonis and Rūta Tikuišytė advised two shareholders of Kilo Health (UAB “Kilo grupė“), one of the leading digital health and wellness companies, in selling minor part of their shares to Scandinavian and Estonian funds.

  • 31.03.2022

    TGS Baltic advised on the largest healthcare clinic merger in Lithuania

    TGS Baltic represented InMedica and its shareholders INVL Baltic Sea Growth Fund, one of the largest Baltic private equity funds, and UAB Litgaja, the holding company of Mr. Kęstutis Broniukaitis, the founder and the CEO of InMedica, on merging the leading Lithuanian private medical chains InMedica and MediCA Group. This is the largest transaction in Lithuanian healthcare sector to date.

  • 10.01.2022

    TGS Baltic advised InMedica on acquiring a plastic surgery centre in Kaunas

    We advised the chain of medical clinics InMedica on the acquisition of a private Saulius Vikšraitis' Plastic Surgery Center in Kaunas, which provides plastic and reconstructive surgery services.

  • 15.12.2021

    TGS Baltic successfully represented Biorro in an unfair competition case

    The TGS Baltic team successfully proved to both the Court of First Instance and the Court of Appeal Instance that former employees of Biorro, acting through another company, unfairly disclosed and exploited trade secrets of the company, and thus poached one of the company's clients.


  • 16.06.2021

    TGS Baltic advised Kilo Health on EUR 300 000 investment in the startup Revolab

    TGS Baltic advised Kilo Health, active in health & wellness global market, on EUR 300 000 investment in Revolab, a Lithuanian startup that has developed a smart blood testing app. The investment will be used for product development in the EU and the US.

  • 14.04.2020

    TGS Baltic provides support in the transaction for the supply of surgical face masks from the People's Republic of China

    On 9 April 2020, a flight with the first cargo delivering one million surgical face masks arrived in Latvia. A total of 2 million surgical masks will be delivered to Latvia. 

  • 14.05.2019

    Advising TBD-Biodiscovery on involving a Dutch investor from SEAL Investments B.V.

    TGS Baltic's team, led by partner Leonid Tolstov, advised the leading Estonian biotechnology company TBD-Biodiscovery and its sole shareholder on involving a Dutch investor from SEAL Investments B.V., who acquired 30% of the company's shares and will be investing a total of EUR 4.5 million in the company in the next few years. This is one of the largest foreign investments in an Estonian biotechnology company.

  • 01.01.2019

    TGS Baltic is a key legal advisor for Lithuanian subsidiary of GlaxoSmithKline

    TGS Baltic is a key legal advisor for Lithuanian subsidiary of GlaxoSmithKline, a science-led global healthcare company. We advised Client on a Pan-Baltic level in a project related to development of internal public procurement policies, ebracing the best practices for various corporate and public procurement issues, including but not limited to protection of confidencial information, fair competition and proper participation in tender produres and etc. These policies reflected boath national regulation and case law, as well as the case law of the European Court of Justice and provisions of the EU public procurement directives.

  • 04.03.2018

    TGS Baltic advised VIKONDA Group, one of the biggest business groups in Lithuania

    TGS Baltic advised VIKONDA Group (VIKONDA Concern), one of the biggest business groups in Lithuania with significant interests in food, trade, crop, media industries, construction, and other services, with a consolidated annual turnover of approximately EUR 145 million, on a complex holding restructuring.


  • 11.09.2017

    TGS Baltic assisted BENU Aptieka Latvija SIA with acquisition of 100% of share of SIA Cēsu Vecpilsētas Aptieka

    Andra Rubene, Attorney at Law, Partner, and Rūdolfs Vilsons, Associate at TGS Baltic assisted BENU Aptieka Latvija SIA, one of the leading retail of medicines chains in the Baltics, with acquisition of 100% shares SIA Cēsu Vecpilsētas Aptieka, a pharmacy in Cēsis, Latvia from a number of private persons, thereby expanding Benu network of more than 66 pharmacies in Latvia.

  • 01.01.2017

    Eugenija Sutkienė awarded as Market Maker for Lithuania

    On 1 June 2017, at a special awards ceremony at the Intercontinental Hotel in Warsaw, Eugenija Sutkienė was named the Market Maker for Lithuania, which is a special lifetime achievement award given to a senior lawyer identified by peers as having played the most influential and significant role in creating the country’s modern legal market

  • 29.09.2016

    Advising Viru Haigla on the acquisition of Karell Kiirabi

    The firm’s M&A team led by associate partner Sander Kärson advised the strategic investor Viru Haigla on the acquisition of Karell Kiirabi from U.S. Invest.

  • 05.02.2015

    Represented the largest orthopaedic technical products company in a dispute with the National Health Insurance Fund

    TGS Baltic successfully represented an orthopaedic technical products manufacturer in Lithuania in a dispute with the National Health Insurance Fund with regard to the right to issue orthopaedic technical products to the patients and receive compensation from state funds.

  • 28.01.2015

    Represented the client in a legal dispute against the Republic of Lithuania

    TGS Baltic successfully represented one of the largest companies in the sector of orthopaedic technical products in a legal dispute against the Republic of Lithuania regarding the refusal to compensate the client for orthopaedic technical products issued by the company to patients (case re State liability).

  • 26.11.2014

    TGS Baltic receives continuing high rankings from IFLR1000 in Baltic countries

    IFLR1000 (International Financial Law Review) is the guide of world’s leading financial law firms. The guide analysis and ranks more than 120 jurisdictions in the world.

  • 01.01.2014

    Northway Group Unique and Long-Term Legal Solutions

    TGS Baltic is the main legal advisor of Northway Group, which consists of 11 companies dealing in pharmacy and biotechnologies, provision of health care services and investments.

  • 01.01.2014

    Novo Nordisk Optimization of Medical-Product Supply Chain in Baltic Region

    TGS Baltic advised Novo Nordisk on the reorganization of its supply chain for medicinal products in the Baltic States, and prepared the relevant documentation.

  • 01.01.2014

    Operations of a manufacturer and distributor of medicinal products in Latvia

    TGS Baltic provides day-to-day legal assistance to a manufacturer and distributor of medicinal products in Latvia, including regarding discounts for medicinal products offered to hospitals through public tenders and donations of medicinal products to hospitals, clinical trials, safety reporting, suspected unexpected serious adverse reactions, scientific services, M&A and corporate, employment, data protection, bribery and competition law issues.

  • 01.01.2014

    Manufacturers of medicinal products require including of innovative medicinal products in the list of reimbursable medicinal products

    TGS Baltic drafted an agreement of manufacturers of medicinal products with the National Health Service on including of innovative medicinal products in the list of reimbursable medicinal products pursuant to the requirements set by the Cabinet regulations No.899 “Procedures for the Reimbursement of Expenditures for the Acquisition of Medicinal Products and Medicinal Devices Intended for Out-patient Medical Treatment”.